Furthermore, one group showed that CD4+ CD25- T cells could be engineered to ectopically express Foxp3, leading to a phenotype similar to nTregs which suppressed GVHD but preserved GVL effects (31). The gene discussed is FOXP3; the disease is graft versus host disease.